title: Why is there so much geographic variation in clinical outcome in international trials of fibrinolytic therapy?
authors.forename: F
authors.initials: F
authors.lastname: Van de Werf
mesh_terms: D006348:Cardiac Surgical Procedures; D002986:Clinical Trials as Topic; D005060:Europe / Q000453:epidemiology; D005061:Europe, Eastern / Q000453:epidemiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005843:Geography; D006761:Hospitals; D006801:Humans; D007843:Latin America / Q000453:epidemiology; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy; D009656:North America / Q000453:epidemiology; D010361:Patients; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents